Companies / United Kingdom
Pharmaceutical Distribution Revolution Accelerates
December 2006 | Company News AlertTwo more multinational pharmaceutical companies have joined market leader Pfizer in rationalising their UK supply chain in an effort to prevent counterfeit products hitting the market. Furthermore, other major drugmakers are considering similar plans, demonstrating that a distinct trend has emerged. The announcements have been heavily criticised by distributors and pharmacies who envisage both lost business and potential product shortages.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
